Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
13.93
-0.29 (-2.04%)
May 28, 2025, 4:00 PM - Market closed
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $27.40 million as of May 28, 2025. Its market cap has increased by 252.56% in one year.
Market Cap
27.40M
Enterprise Value
20.06M
1-Year Change
252.56%
Ranking
Category
Stock Price
$13.93
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $27.40M, a decrease of -52.91%. That is a compound annual growth rate of -27.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2025 | 27.97M | 8.28% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 651.06B |
| Johnson & Johnson | 368.73B |
| AbbVie | 328.06B |
| Novo Nordisk | 313.75B |
| UnitedHealth Group | 267.61B |
| Abbott Laboratories | 231.29B |
| Novartis AG | 221.98B |
| AstraZeneca | 219.74B |